Australia markets open in 6 hours 43 minutes

Chimeric Therapeutics Limited (CHM.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.2700+0.0100 (+3.85%)
At close: 04:10PM AEDT
Full screen
Previous close0.2600
Open0.2700
Bid0.2650 x 24502200
Ask0.2700 x 16334300
Day's range0.2650 - 0.2700
52-week range0.2400 - 0.4400
Volume505,638
Avg. volume747,282
Market cap90.03M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)-0.0830
Earnings date30 Aug 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Diamond Equity Research Emerging Growth Invitational Winter 2021 Spotlight Virtual Conference

    30 Minute presenting time slots from 9am to 1pm EST November 16, 2021Presentation times and links distributed for all presenting companiesInvestors will be provided time after presentation to ask questionsWelcome all institutional and retail investors NEW YORK, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Investors can register at https://www.diamondequityresearch.com/conferences/ or using the company specific links below. Virtual Agenda – Tuesday, November 16, 2021 9:00am-9:30amVolitionRX Limited (NYSE: V

  • GlobeNewswire

    Diamond Equity Research Initiates Coverage on Chimeric Therapeutics Ltd. (ASX:CHM.AX)

    NEW YORK, Oct. 25, 2021 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has initiated coverage of Chimeric Therapeutics Ltd. (ASX:CHM.AX). The in-depth 41-page initiation report includes detailed information on the Chimeric Therapeutics’ business model, services, industry, valuation, management, and risks. The full research report is available here. Highlights from the report include: Promising Pipeline Positioning

  • Simply Wall St.

    Will Chimeric Therapeutics (ASX:CHM) Spend Its Cash Wisely?

    There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...